Amicus Therapeutics Inc (FOLD.OQ)

FOLD.OQ on NASDAQ Stock Exchange Global Market

7.69USD
30 Jan 2015
Change (% chg)

$-0.35 (-4.35%)
Prev Close
$8.04
Open
$7.98
Day's High
$8.09
Day's Low
$7.60
Volume
334,222
Avg. Vol
471,164
52-wk High
$9.61
52-wk Low
$1.76

FOLD.OQ

Chart for FOLD.OQ

About

Amicus Therapeutics, Inc., is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of next-generation medicines for a range of rare and orphan diseases, with a focus on improved therapies for lysosomal storage disorders. The Company’s development programs include next-generation... (more)

Overall

Beta: 1.73
Market Cap(Mil.): $734.83
Shares Outstanding(Mil.): 95.56
Dividend: --
Yield (%): --

Financials

  FOLD.OQ Industry Sector
P/E (TTM): -- 37.76 38.54
EPS (TTM): -0.90 -- --
ROI: -69.63 18.79 18.06
ROE: -171.84 19.44 18.83
Search Stocks

Amicus lead drug nears approval as late-stage trial succeeds

- Amicus Therapeutics Inc is a step closer to bringing its first drug to the market after trial data paved the way for its lead drug to become the first oral treatment for patients with a disorder that causes an abnormal build-up of fat.

20 Aug 2014

UPDATE 3-Amicus lead drug nears approval as late-stage trial succeeds

* Migalastat as effective as standard therapies for Fabry disease

20 Aug 2014

Amicus's fat accumulation drug effective in second late-stage study

Aug 20 - Amicus Therapeutics Inc said its experimental drug was as effective as enzyme replacement therapies (ERTs) after 18 months in patients with an inherited disorder that leads to the abnormal build-up of fat.

20 Aug 2014

Competitors

  Price Chg
Sanofi SA (SASY.PA) €82.00 -0.26
Shire PLC (SHP.L) 4,854.00p -44.00
Shire PLC (3159084.L) -- --
Actelion Ltd (ATLN.VX) CHF102.00 +1.20
Protalix BioTherapeutics Inc. (PLX.TA) 802.00₪ -12.20

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks